DexCom, Inc. Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
DexCom (DXCM) Reports Revenue In-Line with Pre-Release; Piper Jaffray Reiterates Overweight
November 5, 2015 9:53 AM ESTPiper Jaffray reiterated an Overweight rating on DexCom (NASDAQ: DXCM), and raised the price target to $107.00 (from $103.00), following the company's 3Q15 earnings report. DXCM reported revenue of $105.2M, in-line with its pre-release on October 15. 3Q results do not include $800K of revenue deferrals to 4Q related to... More
DexCom (DXCM) Misses Q3 EPS by 6c
November 4, 2015 4:15 PM ESTDexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.07), $0.06 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $105.2 million versus the consensus estimate of $99.88 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
... More


